Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentrica Regulatory News (CNA)

Share Price Information for Centrica (CNA)

Share Price is delayed by 15 minutes
Get Live Data
171.80    0.80 (0.47%)
Bid:
171.70
Ask:
171.85
Spread: 0.15 (0.087%)
Market Cap: £7.78b
CNA Live PriceLast checked at - London Stock Exchange

Intraday Centrica Share Chart

Director/PDMR Shareholding

28 Mar 2025 16:00

RNS Number : 7482C
Centrica PLC
28 March 2025
 

Centrica plc (the "Company")

28 March 2025

Notification of Transactions of Directors

The Company announces the following transactions in respect of the Company's Ordinary Shares of 6 14/81 pence ("Shares") relating to Executive Directors.

The following notifications, made pursuant to Article 19 of the Market Abuse Regulation, provide further details.

Grant of Awards

Restricted Share Plan (RSP) awards of Shares were granted on 27 March 2025 to two Executive Directors.

The awards were granted under the terms of the Centrica Long Term Incentive Plan.

Release of the RSP awards is subject to continued employment and the satisfaction of an underpin, assessed over the three-year period 2025 to 2027. In assessing the underpin, the Remuneration Committee will consider the Company's overall performance including financial and non-financial performance over the course of the vesting period, as well as any material risk or regulatory failures identified. Post vesting, the Shares are subject to a mandatory additional two-year holding period.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name(s)

Chris O'Shea

2

Reason for the notification

a)

Position/status

Executive Director

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Centrica plc

b)

LEI

E26EDV109X6EEPBKVH76

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial

instrument, type of instrument

 

Identification code

Ordinary Shares of 6 14/81 pence

 

 

GB00B033F229

b)

Nature of the transaction

Grant of RSP Award under the Centrica Long Term Incentive Plan.

The number of Shares calculated by reference to a price of £1.4647, being the average of the Company's Share price over the five trading days immediately preceding the date of grant.

c)

Price(s) and volume(s)

 

Price

Volume

£1.4647

1,126,510

d)

Aggregated information

 

- Aggregated volume

- Price

 

 

 

1,126,510

£1,650,000

 

e)

Date of the transaction

27 March 2025

f)

Place of the transaction

Outside a trading venue

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name(s)

Russell O'Brien

2

Reason for the notification

a)

Position/status

Executive Director

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Centrica plc

b)

LEI

E26EDV109X6EEPBKVH76

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial

instrument, type of instrument

 

Identification code

Ordinary Shares of 6 14/81 pence

 

 

GB00B033F229

b)

Nature of the transaction

Grant of RSP Award under the Centrica Long Term Incentive Plan.

The number of Shares calculated by reference to a price of £1.4647, being the average of the Company's Share price over the five trading days immediately preceding the date of grant.

c)

Price(s) and volume(s)

 

Price

Volume

£1.4647

546,186

d)

Aggregated information

 

- Aggregated volume

- Price

 

 

 

546,186

£800,000

 

e)

Date of the transaction

27 March 2025

f)

Place of the transaction

Outside a trading venue

 

Acquisition of Shares

On 27 March 2025, Shares were acquired by Executive Directors as a result of the Annual Incentive Plan award relating to the 2024 financial year. The Shares are subject to a three-year holding period.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name(s)

Chris O'Shea

2

Reason for the notification

a)

Position/status

Executive Director

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Centrica plc

b)

LEI

E26EDV109X6EEPBKVH76

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial

instrument, type of instrument

 

Identification code

Ordinary Shares of 6 14/81 pence

 

 

 

GB00B033F229

b)

Nature of the transaction

Ordinary Shares acquired as a deferred award under the Annual Incentive Plan relating to the 2024 financial year.

c)

Price(s) and volume(s)

Price

Volume

£1.485727

467,574

d)

Aggregated information

 

- Aggregated volume

- Price

 

 

 

467,574

£694,687.32

 

e)

Date of the transaction

27 March 2025

f)

Place of the transaction

Outside a trading venue

 

Details of the person discharging managerial responsibilities/person closely associated

Name(s)

Russell O'Brien

Reason for the notification

Position/status

Executive Director

Initial notification/Amendment

Initial Notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Centrica plc

LEI

E26EDV109X6EEPBKVH76

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial

instrument, type of instrument

 

Identification code

Ordinary Shares of 6 14/81 pence

 

 

 

GB00B033F229

Nature of the transaction

Ordinary Shares acquired as a deferred award under the Annual Incentive Plan relating to the 2024 financial year.

Price(s) and volume(s)

Price

Volume

£1.485727

241,990

Aggregated information

 

- Aggregated volume

- Price

 

 

 

241,990

£359,531.08

 

Date of the transaction

27 March 2025

Place of the transaction

Outside a trading venue

 

 

Centrica plc is listed on the London Stock Exchange (CNA)

Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD

Registered in England & Wales number: 3033654

Legal Entity Identifier number: E26EDV109X6EEPBKVH76

ISIN number: GB00B033F229

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHPPUAWWUPAGWR
Date   Source Headline
10th Nov 20257:00 amRNSTransaction in Own Shares
7th Nov 20257:00 amRNSTransaction in Own Shares
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSTransaction in Own Shares
4th Nov 202512:26 pmRNSCompletion of investment in Sizewell C
4th Nov 20257:00 amRNSTransaction in Own Shares
3rd Nov 20255:30 pmBUSBlock listing Interim Review
3rd Nov 20253:15 pmRNSTotal Voting Rights
3rd Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 20252:30 pmRNSDirector/PDMR Shareholding
31st Oct 20257:00 amRNSTransaction in Own Shares
30th Oct 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:00 amRNSTransaction in Own Shares
28th Oct 20257:00 amRNSTransaction in Own Shares
27th Oct 202512:30 pmRNSDirector/PDMR Shareholding
27th Oct 20257:00 amRNSTransaction in Own Shares
24th Oct 20257:00 amRNSTransaction in Own Shares
23rd Oct 20257:00 amRNSTransaction in Own Shares
22nd Oct 20257:00 amRNSTransaction in Own Shares
21st Oct 20257:00 amRNSTransaction in Own Shares
20th Oct 20257:00 amRNSTransaction in Own Shares
17th Oct 20257:00 amRNSTransaction in Own Shares
16th Oct 20257:00 amRNSTransaction in Own Shares
15th Oct 20257:00 amRNSTransaction in Own Shares
14th Oct 20257:00 amRNSTransaction in Own Shares
13th Oct 20252:00 pmRNSDirector/PDMR Shareholding
13th Oct 20257:00 amRNSTransaction in Own Shares
10th Oct 20257:00 amRNSTransaction in Own Shares
9th Oct 20257:00 amRNSTransaction in Own Shares
8th Oct 20257:00 amRNSTransaction in Own Shares
7th Oct 20257:00 amRNSTransaction in Own Shares
6th Oct 20257:00 amRNSTransaction in Own Shares
3rd Oct 20257:00 amRNSTransaction in Own Shares
2nd Oct 20257:00 amRNSTransaction in Own Shares
1st Oct 20254:15 pmRNSTotal Voting Rights
1st Oct 20257:00 amRNSCompletion of Cygnus gas field interest sale
1st Oct 20257:00 amRNSTransaction in Own Shares
30th Sep 20257:00 amRNSTransaction in Own Shares
29th Sep 20257:00 amRNSTransaction in Own Shares
26th Sep 20257:00 amRNSTransaction in Own Shares
25th Sep 202512:15 pmRNSDirector/PDMR Shareholding
25th Sep 20257:00 amRNSTransaction in Own Shares
24th Sep 20257:00 amRNSTransaction in Own Shares
23rd Sep 20257:00 amRNSTransaction in Own Shares
22nd Sep 20255:00 pmRNSCancellation of treasury shares
22nd Sep 20257:00 amRNSNext tranche of Share Buyback programme commences
22nd Sep 20257:00 amRNSDirectorate Change
22nd Sep 20257:00 amRNSTransaction in Own Shares
19th Sep 20257:00 amRNSTransaction in Own Shares
18th Sep 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.